Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01038557 · ClinicalTrials.gov registry record · NA

Frozen Red Blood Cell Transfusions in Trauma Patients

A NA study of Anemia and Trauma, sponsored by Oregon Health and Science University.

Completed
Registry status
NA
Development phase
254
Enrollment target
5
Study locations

NCT01038557: Completed NA study of Anemia and Trauma, sponsored by Oregon Health and Science University.

NCT01038557 is a NA study of Anemia and Trauma that has completed, run by Oregon Health and Science University. The registered enrollment target is 254 participants, below the 424-participant average among 72 other Anemia trials with a reported enrollment target (40% lower). The trial reports 5 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01038557, a NA study of Anemia and Trauma, has completed, sponsored by Oregon Health and Science University.

COMPLETED
Registry status
NA
Development phase
254 participants
Enrollment target
5
Study locations

Study Summary

The purpose of this study is to look at red blood cell (RBC) transfusions in trauma patients and evaluate for any differences between the age of the RBCs and how they were stored. The investigators will specifically look for the following differences between study groups: 1. the transfused red blood cells' ability to delivery oxygen to the tissues 2. differences in biochemical markers in subjects and units transfused, and 3. how the subject's internal organs are working and if they develop any infections

Primary Outcome

Assessment of tissue oxygenation by NIRS in subjects up to 3 hours after PRBC transfusion.

Interventions

  • BIOLOGICAL RBC units

Study Locations (5)

Texas

  • University of Texas Southwestern Medical Center - Dallas
  • University of Texas Health Science Center at Houston - Houston
  • University of Texas Health Science Center at San Antonio - San Antonio

Ohio

  • University of Cincinnati - Cincinnati

Oregon

  • Oregon Health & Science University - Portland

Trial Details

FieldValue
Enrollment Target 254 participants
Start Date 2010-01
Est. Completion 2014-05
Phase NA

What the finished NCT01038557 record still lists

NCT01038557 is an interventional study that assigns participants to a tested intervention. The registered 254 participants enrollment target is mid-sized for trials with a published cap, below the 424-participant average among 72 other Anemia trials with a reported enrollment target (40% lower).

The record links to 3 conditions, with Anemia appearing as the primary indexed condition, and to 1 intervention - of which RBC units is the first listed.

NCT01038557 lists 5 locations in 3 states (Texas, Ohio, Oregon).

Frequently Asked Questions

What is clinical trial NCT01038557 about?

NCT01038557 is a clinical study titled "Frozen Red Blood Cell Transfusions in Trauma Patients". The purpose of this study is to look at red blood cell (RBC) transfusions in trauma patients and evaluate for any differences between the age of the RBCs and how they were stored. The investigators will specifically look for the following differences between study groups: 1. the transfused red bloo...

What is the current status of trial NCT01038557?

This trial is currently completed. It is a NA study. The enrollment target is 254 participants. The study started on 2010-01. Estimated completion is 2014-05.

What conditions does trial NCT01038557 study?

This clinical trial studies the following conditions: Anemia, Trauma, Blood Loss.

What interventions are being tested in trial NCT01038557?

The interventions under investigation include: RBC units (BIOLOGICAL).

Who is sponsoring clinical trial NCT01038557?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01038557 being conducted?

This trial has 5 study locations across Ohio, Oregon, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01038557's enrollment target sits among peer trials

254 30th of 72 higher than 43 of 72 other Anemia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Anemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04390737 · 254 participants · Phase 1

    Evaluate the Safety and Clinical Activity of HH2853

  • NCT04677647 · 254 participants · NA

    OurChild: A Health IT Solution to Reduce Minority Health Disparities

  • NCT05503797 · 254 participants · Phase 2

    A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  • NCT06167317 · 254 participants · Phase 1

    Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01038557, the US trial registry maintained by the National Library of Medicine. NCT01038557 (mid enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.